Simplex Trading, LLC 2seventy Bio, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$3.09 - $6.0 $4,307 - $8,364	1,394 Added 17.22%	9,491 $50,000
Q4 2023 Feb 02, 2024	BUY	$1.57 - $4.58 $12,426 - $36,250	7,915 Added 4348.9%	8,097 $34,000
Q3 2023 Nov 01, 2023	SELL	$3.14 - $11.2 $1,912 - $6,820	-609 Reduced 76.99%	182 $0
Q2 2023 Aug 04, 2023	BUY	$8.45 - $12.48 $6,683 - $9,871	791 New	791 $8,000
Q4 2022 Feb 02, 2023	SELL	$8.57 - $17.0 $9,735 - $19,312	-1,136 Reduced 19.23%	4,770 $44,000
Q3 2022 Nov 04, 2022	BUY	$12.56 - $17.54 $13,941 - $19,469	1,110 Added 23.14%	5,906 $85,000
Q2 2022 Aug 03, 2022	BUY	$10.55 - $18.81 $50,597 - $90,212	4,796 New	4,796 $63,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $118M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.